Effect of Naoxintong on Serum Lipid Level in Patients with Acute Coronary Syndrome
10.3760/cma.j.issn.1008-6706.2010.12.006
- VernacularTitle:脑心通对急性冠脉综合征患者血脂及超敏C反应蛋白的影响
- Author:
Lihua YANG
- Publication Type:Journal Article
- Keywords:
Atorvastatin;
Naoxintong capsule;
Coronary disease;
C-reactive protein;
Serum Lpid
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(12):1597-1598
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of atorvastatin combined with Naoxintong capsules on serum lipid level and hish sensitivity C-reactive protein(hs-CRP)in patients with acute coronary syndrome(ACS).Methods 82 ACS patients were randomly divided into observation group(10 mg/d of atorvastatin and 4 capsules 3 times of Naoxintong daily,n=41) and control group(20 mg/d of simvastatin daily,n=41).The levels of serum lipid and hs-CRP were detected before and after treatment.Results 8 weeks after treatment,the levels of serum hpid[TC (4.21±0.87)mmol/L,TG(1.99±0.48)mmol/L,LDL-C(2.71±0.83) mmol/L] and serum hs-CRP(5.63±1.38)mg/L in observation group were significantly lower than those in control group[TC(4.89±0.91)mmol/L,TG (2.58±0.52)mmol/L,LDL-C(3.28±0.89)mmol/L],and serum level HDL-C(1.89±0.47)mmol/L was higher than that in control group(1.63±0.45)mmol/L(t=2.55-4.36,P<0.01～0.05).Conclusion Adjuvant therapy of Naoxintong could promote the levels of serum lipid and hs-CRP in patients with ACS.and offer a better therapeutic effect in these patients.
